Cargando…
Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis
The solute carrier family 6 member 14 (SLC6A14) protein imports and concentrates all neutral amino acids as well as the two cationic acids lysine and arginine into the cytoplasm of different cell types. Primarily described as involved in several cancer and colonic diseases physiopathological mechani...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426304/ https://www.ncbi.nlm.nih.gov/pubmed/32166393 http://dx.doi.org/10.1007/s00018-020-03487-x |
_version_ | 1783570653126852608 |
---|---|
author | Ruffin, Manon Mercier, Julia Calmel, Claire Mésinèle, Julie Bigot, Jeanne Sutanto, Erika N. Kicic, Anthony Corvol, Harriet Guillot, Loic |
author_facet | Ruffin, Manon Mercier, Julia Calmel, Claire Mésinèle, Julie Bigot, Jeanne Sutanto, Erika N. Kicic, Anthony Corvol, Harriet Guillot, Loic |
author_sort | Ruffin, Manon |
collection | PubMed |
description | The solute carrier family 6 member 14 (SLC6A14) protein imports and concentrates all neutral amino acids as well as the two cationic acids lysine and arginine into the cytoplasm of different cell types. Primarily described as involved in several cancer and colonic diseases physiopathological mechanisms, the SLC6A14 gene has been more recently identified as a genetic modifier of cystic fibrosis (CF) disease severity. It was indeed shown to have a pleiotropic effect, modulating meconium ileus occurrence, lung disease severity, and precocity of P. aeruginosa airway infection. The biological mechanisms explaining the impact of SLC6A14 on intestinal and lung phenotypes of CF patients are starting to be elucidated. This review focuses on SLC6A14 in lung and gastrointestinal physiology and physiopathology, especially its involvement in the pathophysiology of CF disease. |
format | Online Article Text |
id | pubmed-7426304 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-74263042020-08-19 Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis Ruffin, Manon Mercier, Julia Calmel, Claire Mésinèle, Julie Bigot, Jeanne Sutanto, Erika N. Kicic, Anthony Corvol, Harriet Guillot, Loic Cell Mol Life Sci Review The solute carrier family 6 member 14 (SLC6A14) protein imports and concentrates all neutral amino acids as well as the two cationic acids lysine and arginine into the cytoplasm of different cell types. Primarily described as involved in several cancer and colonic diseases physiopathological mechanisms, the SLC6A14 gene has been more recently identified as a genetic modifier of cystic fibrosis (CF) disease severity. It was indeed shown to have a pleiotropic effect, modulating meconium ileus occurrence, lung disease severity, and precocity of P. aeruginosa airway infection. The biological mechanisms explaining the impact of SLC6A14 on intestinal and lung phenotypes of CF patients are starting to be elucidated. This review focuses on SLC6A14 in lung and gastrointestinal physiology and physiopathology, especially its involvement in the pathophysiology of CF disease. Springer International Publishing 2020-03-12 2020 /pmc/articles/PMC7426304/ /pubmed/32166393 http://dx.doi.org/10.1007/s00018-020-03487-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Ruffin, Manon Mercier, Julia Calmel, Claire Mésinèle, Julie Bigot, Jeanne Sutanto, Erika N. Kicic, Anthony Corvol, Harriet Guillot, Loic Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis |
title | Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis |
title_full | Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis |
title_fullStr | Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis |
title_full_unstemmed | Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis |
title_short | Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis |
title_sort | update on slc6a14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426304/ https://www.ncbi.nlm.nih.gov/pubmed/32166393 http://dx.doi.org/10.1007/s00018-020-03487-x |
work_keys_str_mv | AT ruffinmanon updateonslc6a14inlungandgastrointestinalphysiologyandphysiopathologyfocusoncysticfibrosis AT mercierjulia updateonslc6a14inlungandgastrointestinalphysiologyandphysiopathologyfocusoncysticfibrosis AT calmelclaire updateonslc6a14inlungandgastrointestinalphysiologyandphysiopathologyfocusoncysticfibrosis AT mesinelejulie updateonslc6a14inlungandgastrointestinalphysiologyandphysiopathologyfocusoncysticfibrosis AT bigotjeanne updateonslc6a14inlungandgastrointestinalphysiologyandphysiopathologyfocusoncysticfibrosis AT sutantoerikan updateonslc6a14inlungandgastrointestinalphysiologyandphysiopathologyfocusoncysticfibrosis AT kicicanthony updateonslc6a14inlungandgastrointestinalphysiologyandphysiopathologyfocusoncysticfibrosis AT corvolharriet updateonslc6a14inlungandgastrointestinalphysiologyandphysiopathologyfocusoncysticfibrosis AT guillotloic updateonslc6a14inlungandgastrointestinalphysiologyandphysiopathologyfocusoncysticfibrosis |